Ligand Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Amgen USD 8.81B 3.16B 2025-03
Arrowhead Research USD 185.71M 133.92M 2025-03
Baxter International USD 1.76B 344M 2024-12
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Insmed USD 403.25M 151.78M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Ligand Pharmaceuticals USD 256.89M 184.58M 2025-03
MacroGenics USD 182.84M 3.22M 2024-12
Merck USD 8.63B 4.61B 2025-03
Pacira USD 283.61M 6.84M 2025-03
Pfizer USD 1.43B 387M 2025-03
Veracyte USD 239.09M 34.99M 2024-12



Ligand Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.